Growth Metrics

Kestra Medical Technologies (KMTS) Free Cash Flow (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Free Cash Flow for 3 consecutive years, with -$28.2 million as the latest value for Q1 2026.

  • Quarterly Free Cash Flow fell 222.49% to -$28.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$111.9 million through Jan 2026, down 49.57% year-over-year, with the annual reading at -$79.5 million for FY2025, 5.89% up from the prior year.
  • Free Cash Flow for Q1 2026 was -$28.2 million at Kestra Medical Technologies, down from -$25.6 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$8.7 million in Q1 2025, with the low at -$34.4 million in Q3 2025.
  • Average Free Cash Flow over 3 years is -$23.3 million, with a median of -$24.1 million recorded in 2024.
  • The sharpest move saw Free Cash Flow decreased 13.8% in 2025, then tumbled 222.49% in 2026.
  • Over 3 years, Free Cash Flow stood at -$22.5 million in 2024, then dropped by 13.8% to -$25.6 million in 2025, then fell by 9.98% to -$28.2 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$28.2 million, -$25.6 million, and -$34.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.